Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Pediatric Neurology|January 31, 2026
Advancing Neuropediatric Rare Disease Diagnosis Through Clinical Genome SequencingFabio Sirchia, Silvia Kalantari, Diana Carli, et al.Frontiers in Pediatrics|September 7, 2023
Outcomes of MIS-C patients treated with anakinra: a retrospective multicenter national studyFrancesco Licciardi, Carlotta Covizzi, Marta Dellepiane, et al.Mediators of Inflammation|June 23, 2020
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA NetworkAntonio Vitale, Jurgen Sota, Laura Obici, et al.International Journal of Immunopathology and Pharmacology|December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficienciesClementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.Medrxiv : the Preprint Server for Health Sciences|September 12, 2022
Deep immune profiling uncovers novel associations with clinical phenotypes of Multisystem Inflammatory Syndrome in Children (MIS-C)Christopher Redmond, Moses M Kitakule, Aran Son, et al.Annals of the Rheumatic Diseases|July 7, 2019
Clinical characteristics and genetic analyses of 187 patients with undefined autoinflammatory diseasesNienke M Ter Haar, Charlotte Eijkelboom, Luca Cantarini, et al.Rheumatology (Oxford, England)|February 5, 2025
Towards the definition of disease phenotypes in paediatric SAPHO syndrome: a national multicentric studyCaterina Matucci-Cerinic, Anna Attico, Clara Malattia, et al.The Journal of Allergy and Clinical Immunology. in Practice|March 30, 2019
Immunophenotype Anomalies Predict the Development of Autoimmune Cytopenia in 22q11.2 Deletion SyndromeDavide Montin, Agostina Marolda, Francesco Licciardi, et al.The Journal of Pediatrics|December 5, 2022
Pediatric Recurrent Pericarditis: Appropriateness of the Standard of Care and Response to IL-1 BlockadeRoberta Caorsi, Antonella Insalaco, Francesca Bovis, et al.Rheumatology (Oxford, England)|August 3, 2021
Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohortArianna De Matteis, Claudia Bracaglia, Denise Pires Marafon, et al.Pageof 6